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Introduction
Vanadium is one of the essential human bio-elements. It was 
discovered in 1801 by the Spanish chemists Andrés Manuel del 
Rion. This discovery, however, has not been recognized by the 
world of science and was rediscovered by Nils Gabriel Sefstrôm, 
a Swedish chemist, in 1831 [1]. At the beginning, his biological 
role was unknown. At the turn of the 19th and 20th centuries, its 
positive effect on the improvement of glycaemia in humans was 
found. These works, however, were controversial because vana-
dium compounds on prisoners were tested. In addition, insulin 
was discovered during this period, which coped better with gly-
cemic control in people with diabetes [2, 3]. The influence of 
vanadium compounds on living organisms up to the 1980s was 
studied only in the toxicological aspect [4-6]. A number of toxic 
effects have been demonstrated in people exposed to vanadium 
at work [7, 8]. The interest in vanadium as an element neces-
sary for living organisms took place only in the 1980s. Then it 
was again presented its glycemic normalization activity. Since 
then, growing interest in vanadium compounds in biological 
terms has been observed. At present, its positive effect on glu-
cose regulation [2, 3, 9-12], serum lipid lowering [13, 14], anti-
oxidant activity in diabetes [15], anticancer activity [16-18], in 
goat reproduction processes [19], in bone growth processes and 
collagen synthesis [20], replacement of phosphates in processes 
using ATP [21] and in a number of others. During the research 
on this element, however, it was found that there are differences 
in its activity depending on the compound used. In bioavaila-
bility studies, it has been shown that organic compounds of this 
element are absorbed better than inorganic compounds [22]. 
In the case of the antidiabetic aspect, inorganic compounds 
were studied at the beginning, McNill’s showed however that 
BMOV (BMOV = bisomaltolatooxidovanadium(IV)] – organ-
ic compound of vanadium worked much better than inorganic 
compounds [23-26]. In addition, the BMOV compound has be-
come soon a standard of antidiabetic properties for other organic 
vanadium compound. Since then, a number of organic vanadi-
um compounds have been tested in various biological aspects. 
Each time, researchers wanted to get the most beneficial effects 
with the smallest side effects that were observed at high doses 
of vanadium. During these works, biochemical effects were de-
scribed without paying attention to the weight of organs. Our 
research shows how the supply of vanadium compounds affects 
the weight of individual organs. Changes in these weights with-
in individual groups may indirectly inform about potential bio-
chemical processes related to particular specific organs.
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Abstract
Vanadium is an element that has an effect on improving glucose levels in animals with diabe-
tes. However, its operation is strongly dependent on the chemical structure of compounds of 
this element. The influence of newly synthesized vanadium compounds on biochemical pro-
cesses is also unknown. The paper presents the influence of eight new vanadium compounds 
on organ weights of animals (mice NZO) in whom diabetes was induced by a high-fat diet 
during 8 weeks. Tested vanadium complexes were administered by 5 weeks. After this time or-
gans were collected and weighed. Tested complexes had a remarkable different effect on organ 
weights, despite having similar composition ([VO(L)(phen)] and the same co-ligand (1,10-phe-
nanthroline). This indicate on separate metabolic pathways of these compounds in the body of 
tested animals and role of the tridentate L Schiff base ligands. The compounds C2, C3 and C5 
shoved biggest influence on organs weight and these results suggest influence on the metabolic 
pathways and therefore are interesting for further investigations.
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Materials and methods
Vanadium complexes
Complexes C1 to C8 were synthesized by chemists from Faculty 
of Chemistry on Jagiellonian University as described in patent 
P.401493. Purity of this complexes were confirmed by elemental 
analysis, IR and UV-VIS spectra as well as by magnetic suscep-
tibility measurements. For several complexes the X-ray crystal 
structure on single crystals were determined. As standards the 
following compound were used: inorganic vanadium salt R1 
– VOSO4 and BMOV [bismaltolatooxidovanadium(IV)]. For 
described in paper vanadium complexes, C1–C8, chemical for-
mulas, ligand compositions, oxidation states of vanadium and 
molecular weights are presented in Table 1.
In Vivo test 
Diet
The animals received two different diets. The first was the 
standard diet for laboratory animals. The other was a high-fat 
one consisting of 15% of saturated fats and 1.5% of cholesterol.
Animals
New Zealand Obese mice (n = 264) in age of 5 weeks were di-
vided into 22 groups of 12 animals (six per cage). Two, from 22 
groups, were as diabetes and healthy control: other 20 groups 
were treated with vanadium compounds. In this groups two ref-
erence vanadium compounds: - inorganic VOSO4 and organic 
BMOV were used. The remaining 18 groups received vanadi-
um complexes C1-C8. Diabetes was induced by special food 
containing cholesterol (1,5%) and saturated fatty acids (15%) 
by period of 8 weeks. After this time, by following 5 weeks, 
tested compounds were administered once per day by gavage in 
dose of 0,063 mmol/kg of animal body mass. In the end of ex-
periment the animals were sacrificed using thiopentone (60mg/
kg) and the organs were isolated and weighed on an analytical 
balance (SartoriusR).
Statistic
All statistical analyzes were performed with the use the Statisti-
ca 13.0 program. To calculate statistically significant differenc-
es, the Tukey test for different N was used. P <0.05 was assumed 
as the significance level.
Symbol Chemical structure Formula (name) Molar mass V
R1 VOSO4 Vanadyl sulfate 163.0 4
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Results
Below are presented graphics as results of experience observa-
tion. These presentation will significantly facilitate understand-
ing of observed changes in particular groups of animals. The 
observed changes are discussed under each graphic.
A) Brain
B) Lungs











































a) No statistical differences between groups (p>0.05).
b)  In the case of mice that received a non-diabetic diet, the weight gain was smaller and for this reason the weight of the brain was statistically 
significantly higher (p>0.001) than the total body weight. The weight of the brain does not increase with increasing body weight.










































a) and  b) There are no statistically significant differences in both cases (p>0.05). The weight of the lungs increases with the weight of the body.
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C) Liver
D) Heart








































a)  The liver weight of all groups of animals with diabetes was statistically greater than animals on a non-diabetic diet. Reference compound R2 
caused a statistically smaller increase in liver mass in relation to C5 compounds (p= 0.049) i C6 (p=0.013). 
b)  The percentage of liver in mice that received compound C3 was highest relative to all groups of animals, however, the differences were 
statistically significant only between the groups R1 (p = 0.005) and R2 (p = 0.010) relative to Compound C3. The C3 and C5 groups had a 
statistically significantly higher % of the liver in the body of the whole animal also in relation to the control group (p = 0.001 and p = 0.015 
respectively).















































a)  The weight of the heart was the highest in C5 animals compared to other groups. The differences were statistically significant between the 
C6 group and the R1, R2, C4, C6 groups (p <0.001, p = 0.002, p = 0.005, p = 0.037, respectively, also complex  C7 statistically increased the 
cardiac mass relative to the R1 group (p = 0.017).
b)  Percentage of the heart in the mass of the whole animal was statistically the highest in the control group healthy in relation to all other groups. 
In the case of the C5 group a statistically significant increase in the percentage of the heart in relation to the groups R1 and C6 was observed 
(p = 0.012 and p = 0.037 respectively).
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E) Spleen
F) Pancreas












































a)  The use of vanadium compounds affected the weight of the spleen. The highest spleen weight was in the C3 group. The differences between 
the C3 group and the R1, R2, C1, C5, C7, C6, FC and NC groups were statistically significant (p <0.001, p <0.001, p <0.001, p = 0.003, 
0.023, p <0.001, p = 0.005 ; p <0.001 respectively).
b)  Taking into account the percentage of weight of the spleen of the animal observations were similar to those in the case of spleen weight.











































a)  In the group of animals with C2 compounds; C3; C4 and C5 showed a lower pancreatic mass than in the other groups. Statistically significant 
differences were observed between R1 and C2 groups (p = 0.049).
b)  Taking into account the percentage of pancreas in the body mass, the highest value was observed in animals in the control group. This value 
was statistically significant between the NC group and the groups: C2; C3; C4 and C5 (p <0.001, p = 0.002, p <0.001 and p 0.005 respective-
ly). In addition, a statistically significant difference was observed between the R1 and C2 groups (p = 0.048).
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G) Left Kidney
H) Right kidney












































a)  There were no statistical differences between the groups, suggesting no effect of obesity and vanadium compounds on the mass of this organ.
b)  In animals from the control group, a statistically significant increase in the percentage of kidney weight was observed compared to that of 
the animal body.














































In the case of the right kidney, the situation was identical to that in the left kidney, both for the body weight and the percentage weight in the 
whole body.
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I) Left testicle
J) Rigt testicle


















































a)  No statistical differences between groups.
b)  In the control group, the percentage of testicular mass in the body mass was statistically higher than in all other groups.




















































a)  Statistically significant reduction in testes weight was observed in animals of group C6 in relation to the group with compound R1.
b)  In the case of the percentage of the right core mass in the whole body mass, a statistically higher percentage was observed in control animals 
in relation to the remaining groups. In addition, statistically significant differences between R1 and C6 were similarly observed (p = 0.048).
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K) Femur
L) Body mass and body mass growth
Discussion
Mass of organs can be quickly technique of investigation of new 
compounds. If organ masses will be different its suggest influ-
ence on different metabolic pathway. Many metabolic dysfunc-
tions affect the organs structure, color or weight. Changes in 
the weight of organs may indicate that they are largely sensitive 
to the tested compounds. In addition, it can indirectly indicate 
which metabolic functions undergo disruption, under the influ-
ence of the tested compounds, and in this way indicate possible 
directions for future biochemical investigations.
Type 2 diabetes is most often associated with an increase in 
body weight. The experiment, presented in this paper, also indi-
cated that the diabetic diet significantly increases the body weight 
of animals. The administration of vanadium compounds did not 
statistically affect the final weight of diabetic animals caused by 
diet. It can be observed however, that the compounds R2 and 
C8 but not significantly reduced the weight of animals. These 
















































a)  The femoral mass varied between groups. The lowest value was observed in the R1 group and the highest in the C6 group. The differences 
were statistically significant between the R1 group and the C1 - C8 groups; FC and NC. There were also statistically significant differences 
between the C5 group and C1 groups; 6; C7; Fc and NC (p = 0.021, p = 0.023, p = 0.002, p <0.001, p = 0.02, respectively).
b)  Taking into account the percentage of femoral mass in the whole body mass, an identical relationship was observed within the groups with 
the diabetic-inducing diet. In the case of the NC Group, the highest proportion of femur in the mass of the whole body was observed statis-
tically significantly in relation to the remaining groups, excluding C3 groups; C4; C5 and C8.





















































a)  The body weights of animals fed a diabetic diet were in each case statistically higher than the mass of animals from the NC group.
b)  Taking into account the weight gain, it was observed that the C2 animals were the highest and the lowest in the NC group. Statistically sig-
nificant differences were observed between the NC group and R1 groups; C1 - C7 and FC. Within animals with a diabetic diet, statistically 
significant differences were observed between the C2 group and the R2 groups; C1; C4 and C8 (p <0.001, p = 0.010, p = 0.030, p <0.001).
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observations confirm the data from other works that in some 
cases a reduction in the final weight of animals, in the groups 
that receive vanadium compounds, is observed [12, 28, 29]. An 
interesting comparison was the recorded gain weight of animals 
from the start of vanadium administration to the end of the ex-
periment. The reference compound and the C8 compound were 
the most responsible for weight decrease in the group of diabetic 
animals induced by diet. In the case of compound C2, a statisti-
cally significant increase in body mass was observed in relation 
to the rest of the tested vanadium compounds.
The weight of organs such as the brain, lungs and testes did 
not differ significantly between the groups and it cannot be said 
that the tested compounds had an observable effect on them. It 
can be noted, however, that the percentage of brain and testes 
was higher in animals from the control group, due to decrease of 
body weight. Such a result shows that regardless of body weight 
and mainly body fat, these organs do not change the weight in 
group of a similar age animals.
A very pronounced effect of the diet is observed in the case 
of liver mass. All animals with diabetic triggered by diet had a 
significantly higher liver weight compared to the healthy control 
group. The graph of liver weight and body weight of animals 
is very similar. One can also observe the effect of particular 
vanadium compounds on liver mass. The C3, C5 and C6 com-
pounds caused the largest increase in the mass of this organ 
while compounds R2 and C8 the smallest. An interesting is the 
graph showing the percentage of liver weight in the total animal 
weight. It can be seen from this graph that compounds C2, C3, 
C5 and C6 increase the percentage of liver in the weight of the 
whole animal. This may indirectly indicate that the structure of 
a particular vanadium compound is important in hepatic metab-
olism. The specific biochemical measurements will be neces-
sary to answer which metabolic changes are induced and which 
are inhibited by the tested compounds.
All tested compounds had an influence also on the mass of the 
heart. The compound C5 increased the body’s mass, this may 
indicate on circulatory problems resulting in an increase in re-
sistance to blood flow which were compensated by hypertrophy 
of the left ventricle.
Spleen is the body in which the production of immunoglobu-
lins, as well as the processing of “old” blood cells, takes place. 
Increasing the weight of the spleen can indirectly suggest the 
influence of the test compounds on hematopoietic and immune 
processes. The highest increase in spleen weight is observed for 
the compound C3. Unfortunately, we are not able to discuss the 
nature of these changes without additional biochemical tests.
The main secretory function of the pancreas is the production 
of insulin, which is supposed to reduce the level of glucose. In 
the case of diabetes type 2, an increase in insulin resistance is 
observed as the body weight increases. In the conducted exper-
iment, a decrease in body weight of this organ is observed in 
groups of animals receiving compounds (C2), C3, C4 and C5. 
Such a change may indicate a probable increase in insulin sen-
sitivity, which results in a lower production of insulin needed to 
normalize the glucose level.
The primary function of the kidney is to remove protein me-
tabolism products and to maintain water and electrolyte balance. 
The observation of the kidney weight showed that after admin-
istration of C3 and C5 compounds, that the weight of this organ 
increases in relation to the other compounds. Most often, kidney 
hypertrophy is associated with an increase in blood pressure or 
inflammatory problems in the urinary tract. However, the nature 
of these changes requires further investigations.
One of the biggest changes was observed in the weight of the 
femur. Compound C5 caused the largest increase in femur mass. 
This may indicate the degree of bone mineralization. Some 
studies have shown that vanadium compounds are actively in-
volved in the processes of bone formation and these observa-
tions have coverage for some of the vanadium compounds tested 
in this paper [20].
Conclusion
Tested in this work vanadium compounds C1–C8, despite hav-
ing similar composition ([VO(L)(phen)] and the same co-ligand 
(1,10-phenanthroline) had a remarkable different effect on organ 
weights. This indicate on separate metabolic pathways of these 
compounds in the body of tested animals and role of the triden-
tate L Schiff base ligands.
The compounds C2 – {N-(E)[-(5-bromo-2-oxophenyl)
methylidene]-4-chlorobenzene-1-carbohydrazonate)}(1,10-phe-
nanthroline)oxidovanadium(IV); C3 – (4-bromo-2-{(E)-
[2-(4-tetr-buthylbenzoyl)hydrazinylidene]methyl}phenolate)
(1,10-phenanthroline)oxidovanadium(IV)·0.5H2O and C5 – 
(4-bromo-2-{(E)-[2-(4-hydroxybenzoyl)hydrazinylidene]me-
thyl}phenolate)(1,10-phenanthroline)oxidovanadium(IV)·2H2O 
have a significant influence on the organs weight, which can 
inform about their large impact on the metabolic pathways and 
therefore are interesting for further investigations. At this mo-
ment it is impossible to esplicate what decide about observed 
data. Future biochemical analysis can answer what decide about 
observed data.
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